MELK anticorps (AA 637-651)
Aperçu rapide pour MELK anticorps (AA 637-651) (ABIN969538)
Antigène
Voir toutes MELK AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
Clone
-
-
Épitope
- AA 637-651
-
Fonction
- MELK Antibody
-
Séquence
- VYKRLVEDIL SSCKV
-
Purification
- Purified antibody
-
Immunogène
- Synthesized peptide of human MELK(AA: 637-651:C-VYKRLVEDILSSCKV).
-
Isotype
- IgG2a
-
-
-
-
Indications d'application
-
ELISA: 1/10000
FCM: 1/200 - 1/400
ICC: 1/200 - 1/1000
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Purified antibody in PBS with 0.05 % sodium azide.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- 4 °C,-20 °C
-
Stockage commentaire
- Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.
-
-
-
: "Siomycin A targets brain tumor stem cells partially through a MELK-mediated pathway." dans: Neuro-oncology, Vol. 13, Issue 6, pp. 622-34, (2011) (PubMed).
: "Dysregulated expression of Fau and MELK is associated with poor prognosis in breast cancer." dans: Breast cancer research : BCR, Vol. 11, Issue 4, pp. R60, (2009) (PubMed).
-
: "Siomycin A targets brain tumor stem cells partially through a MELK-mediated pathway." dans: Neuro-oncology, Vol. 13, Issue 6, pp. 622-34, (2011) (PubMed).
-
- MELK (Maternal Embryonic Leucine Zipper Kinase (MELK))
-
Autre désignation
- MELK
-
Sujet
- Maternal embryonic leucine-zipper kinase (MELK) is a key regulator of survival of stemlike GBM cells in vitro. MELK expression is increased in breast cancer tissue and this increase is also associated with poor patient survival, as predicted for a candidate oncogene.
-
Poids moléculaire
- 74.6 kDa
-
ID gène
- 9833
-
UniProt
- Q14680
Antigène
-